General Information of Drug (ID: DMGZ3DR)

Drug Name
NT-3 Drug Info
Synonyms Neurotrophin-3; NT-3, Amgen-Regeneron Partners; NT-3, Amgen/ Regeneron; Neurotrophin-3, Amgen-Regeneron Partners; Neurotrophin-3, Amgen/ Regeneron
Indication
Disease Entry ICD 11 Status REF
Constipation DD91.1 Discontinued in Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMGZ3DR

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug(s) Targeting Neurotrophin-3 (NTF3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ReN-1826 DMGY51F Central nervous system disease 8A04-8D87 Terminated [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Neurotrophin-3 (NTF3) TTZHKV9 NTF3_HUMAN Modulator [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5033).
2 NT-3. Takeda/Regeneron/Amgen. IDrugs. 2001 Jul;4(7):820-4.
3 Pulmonary distribution, regulation, and functional role of Trk receptors in a murine model of asthma. J Allergy Clin Immunol. 2006 Sep;118(3):597-605.